Estradiol Benzoate: Synthetic Estrogen Receptor Alpha Agonist for Research

Executive Summary: Estradiol Benzoate (SKU B1941), supplied by APExBIO, is a synthetic estradiol analog with high affinity for estrogen receptor alpha (ERα), showing an IC₅₀ of 22–28 nM in human and animal models (APExBIO). It is insoluble in water but dissolves readily in DMSO (≥12.15 mg/mL) and ethanol (≥9.6 mg/mL), supporting varied assay formats. This compound enables precise investigation of estrogen/progestogen receptor-mediated signaling and hormone-dependent cancer models (see here). Estradiol Benzoate is delivered with ≥98% purity, supported by HPLC, MS, and NMR analysis. It is intended exclusively for scientific research, not for diagnosis or therapy.

Biological Rationale

Estrogen receptor signaling is central to the regulation of reproductive, metabolic, and cellular proliferative processes. Estradiol Benzoate is a synthetic analog structurally related to 17β-estradiol, the principal endogenous estrogen. It acts as an agonist at both estrogen and progestogen receptors, with a primary focus on ERα. In research models, ERα activation modulates gene transcription, cell viability, and feedback within the hypothalamic-pituitary-gonadal axis (Vijayan et al., 2021). Selective ERα agonists like Estradiol Benzoate are vital for dissecting hormone receptor crosstalk and for modeling hormone-dependent cancers. The compound’s well-characterized receptor binding profile aids in quantifying signaling pathway effects without confounding off-target activity (Estradiol Benzoate: Precision Use…; this article extends the discussion to workflow integration and storage stability).

Mechanism of Action of Estradiol Benzoate

Estradiol Benzoate binds to ERα with nanomolar affinity (IC₅₀: 22–28 nM in competitive binding assays under physiological conditions, pH 7.4, 25°C). Upon binding, the ligand-receptor complex undergoes conformational change, translocates to the nucleus, and binds estrogen response elements (EREs) on DNA. This initiates transcription of estrogen-responsive genes involved in cell proliferation, differentiation, and survival. The benzoate ester moiety enhances membrane permeability and intracellular retention, making it suitable for in vitro and in vivo studies. Estradiol Benzoate also demonstrates partial agonism at progestogen receptors, extending its utility in dual receptor studies. Its effect is measurable by downstream gene expression (e.g., upregulation of PR, c-myc, cyclin D1 in cell models). The compound’s activity is dose- and time-dependent, with documented effects at 10–100 nM in cell-based assays (Estradiol Benzoate: Unlocking Quantitative Insights…; this article clarifies analytical strategies for dose-response analyses).

Evidence & Benchmarks

• Estradiol Benzoate (C₂₅H₂₈O₃, MW 376.49 g/mol) binds ERα with IC₅₀ of 22–28 nM in radioligand displacement assays (APExBIO, product data).
• Shows ≥98% purity by HPLC analysis; confirmed by mass spectrometry and NMR (APExBIO, COA).
• Solubility: DMSO ≥12.15 mg/mL, ethanol ≥9.6 mg/mL at 25°C; insoluble in water (APExBIO, product page).
• Stable at -20°C for at least 12 months; solutions should be prepared fresh for each experiment to prevent degradation (APExBIO, storage guidelines).
• Validated for use in hormone receptor binding assays, cell viability/proliferation assays, and as a positive control in estrogenic activity screens (Estradiol Benzoate (SKU B1941): Reliable Solutions…).
• Does not cross-react with androgen or glucocorticoid receptors at ≤100 nM (APExBIO, product data).
• Used as a benchmark agent in studies of hormone-dependent cancer models, including breast and endometrial cancer cell lines (Vijayan et al., 2021).

Applications, Limits & Misconceptions

Estradiol Benzoate is widely adopted in:

• Estrogen receptor signaling research and quantifying ERα-specific responses.
• Hormone receptor binding assays for pharmacological profiling.
• Endocrinology research, including modeling of reproductive function and hormone feedback loops.
• Hormone-dependent cancer research (e.g., for validating estrogenic pathways in breast cancer cell models).
• Dual receptor studies involving progestogen signaling.

See Estradiol Benzoate for full product specifications and validated use-cases.

Common Pitfalls or Misconceptions

• Not for diagnostic or therapeutic use: Estradiol Benzoate is strictly for in vitro and preclinical research; it is not approved for human or veterinary medicine (APExBIO).
• Water insolubility: Attempting to dissolve Estradiol Benzoate directly in aqueous buffers results in precipitation and assay variability.
• Storage at room temperature: Prolonged exposure to ambient conditions accelerates degradation; always store at -20°C.
• Assuming pan-nuclear activity: Estradiol Benzoate primarily activates ERα and has minimal activity at ERβ or non-classical estrogen-related receptors at standard research concentrations.
• Inadequate controls: Omitting vehicle and negative controls can confound interpretation in receptor binding and functional assays.

Workflow Integration & Parameters

Estradiol Benzoate integrates into standard research workflows as follows:

• Stock Preparation: Dissolve in DMSO to prepare 10 mM stock; store aliquots at -20°C. Avoid repeated freeze-thaw cycles.
• Assay Dilution: Final working concentration typically ranges from 1–100 nM for cell signaling and receptor binding assays. Dilute freshly into culture medium containing ≤0.1% DMSO.
• Controls: Include DMSO-only and untreated controls to establish baseline activity.
• Stability: Use prepared solutions within 24 hours at 4°C to ensure activity.
• Quality Control: Confirm batch identity by HPLC and MS prior to use; APExBIO provides batch-specific COA.

This article updates Estradiol Benzoate: Advancing Estrogen Receptor Signaling… by detailing precise workflow conditions and troubleshooting guidelines for reproducibility.

Conclusion & Outlook

Estradiol Benzoate is a gold-standard tool for estrogen receptor alpha-mediated signaling research, offering high affinity, specificity, and validated purity. Its robust solubility in organic solvents and compatibility with quantitative receptor assays facilitate reproducible, high-impact research in endocrinology and hormone-dependent cancers. Future directions include further benchmarking its activity in complex co-culture and 3D tumor models, and integration with next-generation sequencing-based transcriptional profiling.

For additional mechanistic detail and advanced analytical protocols, see Estradiol Benzoate: Unlocking Quantitative Insights…; this article extends the discussion to include stability, solubility, and workflow automation.